Adaptimmune Therapeutics plc (ADAP) PT Lowered to $1.75 at Guggenheim
Tweet Send to a Friend
(Updated - March 26, 2025 6:57 AM EDT)
Guggenheim analyst Michael Schmidt lowered the price target on Adaptimmune Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Michael Schmidt lowered the price target on Adaptimmune Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
